|Annelies Wilder-Smith is Professor of Emerging Infectious Diseases at the London School of Hygiene and Tropical Medicine. She also serves as Consultant to the Initiative of Vaccine Research at the World Health Organization, Geneva, Switzerland, where she is responsible for the SAGE deliberations on the use of the first dengue vaccine, second-generation dengue vaccines, as well as the use of fractional yellow fever vaccination, and developing a technical roadmap for Zika vaccines. A world renowned expert in travel and tropical medicine, she is the Immediate Past President of the International Society of Travel Medicine (ISTM), Past-President of the Asia Pacific Society of Travel Medicine, and Editor-in-Chief of the Journal of Travel Medicine.
Her special research interests include vaccine preventable and emerging infectious diseases, in particular dengue, Zika, yellow fever, chikungunya, influenza and meningococcal disease. With a career spanning almost three decades, she has led and co-led various vaccine trials, published more than 260 scientific papers, edited and co-edited textbooks and travel medicine books, served on various editorial boards and scientific committees, including being editorial consultant to The Lancet. She is the Principal Investigator of an EU funded international consortium called "ZikaPLAN" (https://zikaplan.tghn.org/), and recently completed another 4 year research project on dengue, also funded by the European Commission.
|Declarations of Conflict of Interest|